Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Chemotherapy and Pharmacology, Supplement
Cancer Chemotherapy and Pharmacology, Supplement is not currently indexed in Scopus. Published by Springer Verlag.
Checked against the index lists dated .
ISSN 0943-9404Verify ISSN ↗
Publisher: Springer Verlag
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Cancer Chemotherapy and Pharmacology, Supplement indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2001–2003 (also 1996–1999, 1994)).
What is the impact factor of Cancer Chemotherapy and Pharmacology, Supplement?
Cancer Chemotherapy and Pharmacology, Supplement has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Cancer Chemotherapy and Pharmacology, Supplement and what is its ISSN?
Cancer Chemotherapy and Pharmacology, Supplement is published by Springer Verlag. Its ISSN is 0943-9404.
Is Cancer Chemotherapy and Pharmacology, Supplement in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Cancer Chemotherapy and Pharmacology, Supplement open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Cancer Chemotherapy and Pharmacology, Supplement for 8 years, between 1994 and 2003, with 2 years in that span missing. Coverage ended in 2003, 23 years ago, and Scopus now lists the title as inactive.
How well cited is Cancer Chemotherapy and Pharmacology, Supplement? — open metrics via OpenAlex
Cancer Chemotherapy and Pharmacology, Supplement has an h-index of 0 and a 2-year mean of 0 citations per paper (OpenAlex).
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Cancer Chemotherapy and Pharmacology, Supplement? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2003. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2003
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Springer Verlag
Springer Verlag has 421 other titles in our data; 132 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.